组织细胞肿瘤：在消退但尚未完全消失。
Histiocytic neoplasms: Going, going, but not quite gone.
发表日期：2023 Aug 17
作者：
Matthew Collin
来源：
BRITISH JOURNAL OF HAEMATOLOGY
摘要：
BRAF与MEK抑制剂已彻底改变了高危组织细胞结构肿瘤患者的治疗，但完全的疗效是否意味着可以停药治疗？相关评述：Reiner等人关于组织细胞结构肿瘤患者中靶向治疗中断后的结果。《英国血液学杂志》2023年在线出版。doi：10.1111/bjh.18964.© 2023英国血液学协会和约翰威利及子公司。
BRAF and MEK inhibitors have revolutionised the treatment of patients with high-risk histiocytic neoplasms but does a complete response mean that treatment can be withdrawn? Commentary on: Reiner et al. Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms. Br J Haematol 2023 (Online ahead of print). doi: 10.1111/bjh.18964.© 2023 British Society for Haematology and John Wiley & Sons Ltd.